###begin article-title 0
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 71 75 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 82 97 <span type="species:ncbi:10090">transgenic mice</span>
Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 47 51 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 62 66 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 71 86 <span type="species:ncbi:10090">transgenic mice</span>
cDNA microarray-derived expression profiles of MMTV-Wnt-1 and MMTV-Neu transgenic mice reveal several hundred genes to be differentially expressed at each stage of breast tumor development.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 278 284 278 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 3 8 <span type="species:ncbi:9606">human</span>
###xml 225 229 <span type="species:ncbi:10090">Mice</span>
###xml 245 270 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
###xml 272 276 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
In human breast cancer normal mammary cells typically develop into hyperplasia, ductal carcinoma in situ, invasive cancer, and metastasis. The changes in gene expression associated with this stepwise progression are unclear. Mice transgenic for mouse mammary tumor virus (MMTV)-Wnt-1 exhibit discrete steps of mammary tumorigenesis, including hyperplasia, invasive ductal carcinoma, and distant metastasis. These mice might therefore be useful models for discovering changes in gene expression during cancer development.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 677 683 677 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 154 158 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 165 180 <span type="species:ncbi:10090">transgenic mice</span>
###xml 209 213 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 218 233 <span type="species:ncbi:10090">transgenic mice</span>
We used cDNA microarrays to determine the expression profiles of five normal mammary glands, seven hyperplastic mammary glands and 23 mammary tumors from MMTV-Wnt-1 transgenic mice, and 12 mammary tumors from MMTV-Neu transgenic mice. Adipose tissues were used to control for fat cells in the vicinity of the mammary glands. In these analyses, we found that the progression of normal virgin mammary glands to hyperplastic tissues and to mammary tumors is accompanied by differences in the expression of several hundred genes at each step. Some of these differences appear to be unique to the effects of Wnt signaling; others seem to be common to tumors induced by both Neu and Wnt-1 oncogenes.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 83 87 <span type="species:ncbi:10090">mice</span>
We described gene-expression patterns associated with breast-cancer development in mice, and identified genes that may be significant targets for oncogenic events. The expression data developed provide a resource for illuminating the molecular mechanisms involved in breast cancer development, especially through the identification of genes that are critical in cancer initiation and progression.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 858 859 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 976 977 976 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1229 1230 1229 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 489 494 <span type="species:ncbi:10090">Mouse</span>
###xml 783 788 <span type="species:ncbi:10090">mouse</span>
###xml 844 849 <span type="species:ncbi:9606">human</span>
###xml 941 946 <span type="species:ncbi:10090">mouse</span>
Gene expression arrays are being widely used to improve the classification of human cancers and to improve our understanding of the molecular changes associated with carcinogenesis [1,2]. However, their use in defining expression patterns in tumor evolution and in correlating genotypes with phenotypes has been limited because of the poor availability of tissues at different stages in cancer development and because of the great diversity of genetic backgrounds among individuals [3-5]. Mouse models of cancer have advantages for exploring the use of this method: a partially defined neoplastic genotype, relatively uniform genetic background, and ample sources of tissue samples from different stages in mammary tumor evolution. Some features of expression profiles identified in mouse mammary tumors are shared by patterns seen in RNA from human tumors [6]. By comparing expression patterns of mammary tumors in six different transgenic mouse models, Desai and coworkers [7] have shown that the initiating pathway determines a distinctive expression phenotype in tumors. In addition, using proteins as markers of cell phenotypes, we showed that initiating oncogenes determine the developmental status of mammary tumor cells [8].
###end p 10
###begin p 11
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt </italic>
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt </italic>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 810 812 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 144 169 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
###xml 171 175 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Members of the Wnt gene family were discovered as proto-oncogenes that are frequently activated in mammary tumors arising in mice infected with mouse mammary tumor virus (MMTV) [9,10]. Wnt genes encode extracellular matrix binding proteins that control many developmental processes, including cell fate specification and stem cell renewal; they are also involved in mammary morphogenesis and progenitor cell renewal [11,12]. Made as secreted glycoproteins, Wnt proteins exert their biologic effects by binding to at least two membrane receptors, namely the frizzled and low-density lipoprotein receptor related proteins. As a result of signaling via the 'canonical' pathway, beta-catenin is stabilized, translocates to the nucleus, and transactivates different sets of genes depending on the cellular context [13].
###end p 11
###begin p 12
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 321 327 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 846 847 846 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 945 947 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 72 76 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 316 320 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 327 342 <span type="species:ncbi:10090">transgenic mice</span>
###xml 875 880 <span type="species:ncbi:9606">human</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
Mice expressing Wnt-1 under the control of the enhancer elements in the MMTV long terminal repeat develop extensive hyperplasias of the mammary glands at prepubertal ages, mammary tumors at a median age of 6 months, and sometimes pulmonary metastases ([14]; Podsypanina K, unpublished observations). Tumors in these MMTV-Wnt-1 transgenic mice appear to arise from progenitor cells in the mammary gland, because many cells in both hyperplastic and neoplastic lesions express putative progenitor cell markers (such as Sca-1 and keratin-6) and efflux fluorescent Hoechst 33342 dye - a property that has been associated with stem cells in the hematopoietic system [8,15]. The resulting tumors also contain tumor cells with myoepithelial as well as epithelial markers, implying that they arise from a progenitor cell that gives rise to both lineages [8,15]. Because at least some human breast cancers are also thought to arise from progenitor cells [16], it is important to define better the molecular events that lead to tumor formation in this line of mice.
###end p 12
###begin p 13
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 470 476 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 84 88 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 161 165 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 255 259 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 266 281 <span type="species:ncbi:10090">transgenic mice</span>
###xml 465 469 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 476 491 <span type="species:ncbi:10090">transgenic mice</span>
Here we report the expression profiles at different steps of tumor evolution in the MMTV-Wnt-1 transgenic model, and we compare these profiles with those in the MMTV-Neu transgenic model. We addressed the following questions. Can we follow progression in MMTV-Wnt-1 transgenic mice from hyperplasia to primary tumor? Are differences apparent between tumors induced by different transgenic oncogenes? Can we distinguish tumors with additional genetic alterations in MMTV-Wnt-1 transgenic mice from those without other known genetic alterations?
###end p 13
###begin title 14
Results and discussion
###end title 14
###begin title 15
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 18 22 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 29 44 <span type="species:ncbi:10090">transgenic mice</span>
###xml 125 129 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Mammary tumors in MMTV-Wnt-1 transgenic mice have an expression profile distinct from that seen in mammary tumors induced by MMTV-Neu
###end title 15
###begin p 16
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 215 221 215 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 339 345 339 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 522 527 522 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ErbB2</italic>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HER2</italic>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 210 214 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 221 236 <span type="species:ncbi:10090">transgenic mice</span>
###xml 334 338 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 345 360 <span type="species:ncbi:10090">transgenic mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 594 599 <span type="species:ncbi:9606">human</span>
Comparison of expression profiles of tumors from several transgenic models has led to the identification of expression signatures for different oncogenic pathways [7]. In order to determine whether tumors from MMTV-Wnt-1 transgenic mice also have a distinctive expression profile, we determined the profiles of 23 mammary tumors from MMTV-Wnt-1 transgenic mice and, for comparison, 12 mammary tumors from mice carrying the MMTV-Neu transgene (Tables 1 and 2 provide sample information and a list of all comparisons). Neu (ErbB2/HER2), a proto-oncogene that is amplified in approximately 25% of human breast cancers [17], encodes a member of the epidermal growth factor receptor family of receptor tyrosine kinases [18]. It activates signaling pathways different from those activated by Wnt-1, and the two oncogenes can collaborate in mammary tumorigenesis [19].
###end p 16
###begin p 17
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
The expression profiles of these two sets of tumors were clearly separated into two groups by unsupervised average linkage hierarchical clustering analysis (Figure 1), suggesting that the global expression patterns of these two sets of tumors differ significantly. This finding extends previous reports of significant divergence in histopathobiology, cellular composition, and possibly the cell types of origin between these two groups of tumors [8,20,21].
###end p 17
###begin p 18
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 304 307 304 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 324 326 324 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 465 468 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 652 655 652 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 662 664 662 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha</italic>
###xml 665 668 665 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ras</italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc</italic>
###xml 687 711 687 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">polyoma middle T antigen</italic>
###xml 719 746 719 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">simian virus 40 T/t antigen</italic>
###xml 756 784 756 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">simian virus 40 T/t antigen </italic>
###xml 1106 1107 1106 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1145 1177 1145 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rap1-GTPase activating protein 1</italic>
###xml 1179 1206 1179 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">matrix metalloproteinase 15</italic>
###xml 1212 1217 1212 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD81 </italic>
###xml 87 91 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 276 280 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 299 303 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 647 651 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 657 661 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 670 674 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 682 686 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 719 734 <span type="species:ncbi:10633">simian virus 40</span>
###xml 756 771 <span type="species:ncbi:10633">simian virus 40</span>
###xml 784 799 <span type="species:ncbi:10090">transgenic mice</span>
In an effort to identify genes that are specifically dysregulated in tumors induced by MMTV-Wnt-1, we performed a permutation t-test (see Materials and methods, below, for details) on these two groups of array data. In total, 1,296 genes were differentially expressed between MMTV-Wnt-1-induced and MMTV-Neu-induced tumors (P < 0.001; Table 2 and Additional data file 1). Among the 1,296 genes that we found to be differentially expressed between Wnt-1-induced and Neu-induced tumors, 842 genes are represented in the 8.7k chips used in the previous report [7]. In that study, 672 genes were found to be differentially expressed among tumors from MMTV-Neu, MMTV-Ha-Ras, MMTV-c-Myc, MMTV-polyoma middle T antigen, C3(1)/simian virus 40 T/t antigen, and Wap-simian virus 40 T/t antigen transgenic mice using the 8.7k chips. Comparing the 842 differentially expressed genes in the present study with the 672 genes from the earlier study, we found that 165 genes were present in both lists (Additional data file 1), including 91 of the 178 genes (51%) reported as the Neu-Ras-polyoma middle T antigen cluster [7]. Examples of these 91 genes include Rap1-GTPase activating protein 1, matrix metalloproteinase 15, and CD81 (Additional data file 1).
###end p 18
###begin p 19
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 28 32 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 39 54 <span type="species:ncbi:10090">transgenic mice</span>
###xml 122 126 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 131 146 <span type="species:ncbi:10090">transgenic mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
It should be noted that the MMTV-Wnt-1 transgenic mice had a mixed genetic background that was mostly FVB (>75%), whereas MMTV-Neu transgenic mice were on a pure FVB background. Although this small variation in genetic background between these two groups of mice is unlikely to account for the differences in expression profiles we detected, we cannot exclude the possibility that some of the genes identified by this analysis might be due to variation in genetic background.
###end p 19
###begin p 20
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 393 395 393 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 649 652 649 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 74 78 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 252 256 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 261 276 <span type="species:ncbi:10090">transgenic mice</span>
###xml 644 648 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
A panel of 652 genes were reported to be differentially expressed between MMTV-Neu-induced tumors and normal virgin mammary glands in the study of Desai and coworkers [7] using the 8.7k chips (> two-fold). In the present study comparing 12 tumors from MMTV-Neu transgenic mice and five nontransgenic normal virgin mammary glands using the 15k chips, 1,263 genes were differentially expressed (P < 0.001, more than three-fold; Table 2). Among these 1,263 genes, 626 genes were represented in the 8.7k arrays used by Desai and coworkers. Of these 626 genes, 225 (35%) overlapped with the 652 genes reported to be differentially expressed between MMTV-Neu-induced tumors and normal virgin mammary glands in the study conducted by Desai and colleagues. We consider this to be an acceptable level of reproducibility, considering the multiple differences in the generation of the two data sets (including differences in reference RNAs, array prints, age of the virgin mammary glands, and sample size).
###end p 20
###begin p 21
###xml 39 41 39 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 197 205 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D</italic>
###xml 205 207 205 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 219 225 219 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 237 248 237 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">frizzled 7 </italic>
###xml 264 271 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-5a </italic>
###xml 411 417 411 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 458 462 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 53 57 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 87 91 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 406 410 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 417 432 <span type="species:ncbi:10090">transgenic mice</span>
###xml 453 457 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 462 477 <span type="species:ncbi:10090">transgenic mice</span>
Genes that were more highly expressed (P < 0.001) in MMTV-Wnt-1-induced tumors than in MMTV-Neu-induced tumors include genes reported to be transcriptional targets of Wnt signaling [22-26] such as cyclin D1 (2.0-fold), c-Myc (2.0-fold), frizzled 7 (2.1-fold), and Wnt-5a (9.2-fold; Additional data file 1). Wnt-5b, another member of the Wnt family, was also more highly expressed (3.7-fold) in tumors from MMTV-Wnt-1 transgenic mice than in tumors from MMTV-Neu transgenic mice; it remains to be determined whether this Wnt member is also a transcriptional target of Wnt signaling.
###end p 21
###begin p 22
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 109 132 109 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Retinoic acid receptor </italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stra6</italic>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 331 337 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stra6 </italic>
###xml 338 340 338 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 401 404 401 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 434 467 434 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cellular retinol binding protein </italic>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP</italic>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 550 552 550 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 613 616 613 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 681 686 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP1 </italic>
###xml 714 716 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 362 366 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 396 400 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 574 578 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 608 612 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Retinoic acid signaling has been reported to synergize with Wnt signaling to induce gene expression [27,28]. Retinoic acid receptor and Stra6, a gene activated by the addition of retinoids to cultured cells [29], have also been suggested to be targets of Wnt signaling [27]. Consistent with these reports, we found higher level of Stra6 (P < 0.001, 9.0-fold) in MMTV-Wnt-1-induced tumors than in MMTV-Neu-induced tumors. In addition, cellular retinol binding protein (RBP)1, a gene related to retinoic acid signaling, was also more highly expressed (P < 0.001, two-fold) in MMTV-Wnt-1-induced tumors than in MMTV-Neu-induced tumors, which is consistent with our recent report that RBP1 is induced by beta-catenin [30].
###end p 22
###begin p 23
###xml 5 10 5 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 277 279 277 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 324 335 324 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">calponin 1 </italic>
###xml 351 362 351 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">calponin 2 </italic>
###xml 431 437 431 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 473 477 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 611 617 611 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 706 716 706 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">keratin 6 </italic>
###xml 727 736 727 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tenascin </italic>
###xml 748 777 748 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">osteoblast specific factor 2 </italic>
###xml 789 834 789 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">insulin-like growth factor binding protein 7 </italic>
###xml 850 860 850 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nidogen 1 </italic>
###xml 872 873 872 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 898 900 898 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 929 935 929 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 1062 1067 1062 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 1096 1099 1096 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 1128 1129 1128 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 0 4 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 135 139 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 426 430 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 468 472 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 477 492 <span type="species:ncbi:10090">transgenic mice</span>
###xml 606 610 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 617 632 <span type="species:ncbi:10090">transgenic mice</span>
###xml 924 928 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 935 950 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1057 1061 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1091 1095 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
MMTV-Wnt-1-induced tumors contain both epithelial and myoepithelial cells in approximately equal numbers, unlike tumors induced by the MMTV-Neu transgene, which contain only epithelial tumor cells [8,21,31]. Consistent with these reports, we observed higher expression levels (P < 0.001) of myoepithelial markers, including calponin 1 (12.5-fold) and calponin 2 (2.5-fold and 4.0-fold for two separate clones), in tumors from MMTV-Wnt-1 transgenic than in tumors from MMTV-Neu transgenic mice (Additional data file 1). Consistent with earlier reports that tumors may arise from mammary progenitor cells in MMTV-Wnt-1 transgenic mice [8,15], we found that RNA encoding the candidate progenitor cell markers keratin 6 (13-fold), tenascin (3.1-fold), osteoblast specific factor 2 (2.0-fold), insulin-like growth factor binding protein 7 (2.0-fold), and nidogen 1 (1.8-fold) [8,32] were more abundant (P < 0.001) in tumors from MMTV-Wnt-1 transgenic mice. Using immunoassays, we demonstrated that keratin 6 and nidogen proteins are expressed at higher level in MMTV-Wnt-1-induced tumors than in MMTV-Neu-induced tumors (Figure 1b) [8].
###end p 23
###begin title 24
###xml 97 103 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 92 96 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 103 118 <span type="species:ncbi:10090">transgenic mice</span>
Expression profiles are similar among mammary tumors with additional genetic alterations in MMTV-Wnt-1 transgenic mice
###end title 24
###begin p 25
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 44 48 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 67 71 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 309 313 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 320 335 <span type="species:ncbi:10090">transgenic mice</span>
The distinct patterns of genes expressed in MMTV-Wnt-1-induced and MMTV-Neu-induced tumors described in the preceding section suggest that initiating oncogenes strongly influence gene expression in the tumors arising in these two models. We have observed that other genetic events accelerate tumorigenesis in MMTV-Wnt-1 transgenic mice [14,33]. We next evaluated whether the events that mediate acceleration are reflected in the gene expression patterns.
###end p 25
###begin p 26
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 201 208 201 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 419 426 419 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 455 462 455 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 517 524 517 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 755 762 755 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 898 905 898 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 933 940 933 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 947 948 947 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1006 1008 1006 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1083 1088 1083 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 1106 1109 1106 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 65 69 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 76 91 <span type="species:ncbi:10090">transgenic mice</span>
###xml 376 380 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1078 1082 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1101 1105 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
We recently reported that approximately 50% of mammary tumors in MMTV-Wnt-1 transgenic mice have activating mutations in the Ha-Ras locus [19]. Thus, we first considered whether tumors carrying mutant Ha-Ras have an expression profile distinct from that observed in tumors that are wild-type at the Ha-Ras locus. We sequenced Ha-Ras cDNA to seek mutations in 21 out of the 23 MMTV-Wnt-1-induced tumors: 12 tumors carry Ha-Ras mutations and nine have only Ha-Ras wild-type alleles (Figure 1a). Tumors with and without Ha-Ras mutations did not have distinct global expression profiles (Figure 1a). Independent multidimensional scaling (MDS) and hierarchical clustering of these 21 tumors based on expression profiles also did not separate them according to Ha-Ras status (data not shown). Nevertheless, permutation t test identified 40 genes differentially expressed between tumors bearing wild-type Ha-Ras and those carrying a mutant Ha-Ras (Table 2 and Additional data file 2). This is more than expected (P < 0.001) but many fewer than we saw in our earlier comparison between MMTV-Wnt-1-induced and MMTV-Neu-induced tumors. In addition, the average fold difference is much smaller (Additional data file 2) than that in the earlier comparison.
###end p 26
###begin p 27
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten </italic>
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 311 317 311 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 400 404 400 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten </italic>
###xml 588 594 588 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 790 791 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 880 886 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 94 98 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 105 120 <span type="species:ncbi:10090">transgenic mice</span>
###xml 222 226 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 306 310 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 317 332 <span type="species:ncbi:10090">transgenic mice</span>
###xml 374 378 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 594 609 <span type="species:ncbi:10090">transgenic mice</span>
###xml 875 879 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
We previously determined that loss of either p53 or Pten accelerates mammary tumorigenesis in MMTV-Wnt-1 transgenic mice [34,35]. To further investigate the influence of these genetic alterations on expression patterns in MMTV-Wnt-1-induced tumors, we determined the expression profiles of six tumors from MMTV-Wnt-1 transgenic mice that were p53 null and three tumors from MMTV-Wnt-1 transgenic/Pten+/- mice that had lost the wild-type allele of Pten (i.e. loss of heterozygosity). When genes in the 8.7k array data set from these two groups of tumors and those from 10 tumors from MMTV-Wnt-1 transgenic mice that were otherwise wild-type were subjected to analysis by MDS or unsupervised hierarchical clustering, the three groups of samples could not be separated from each other (Figure 2 and data not shown). These findings suggest that the global expression profiles of MMTV-Wnt-1 tumors carrying different additional genetic alterations cannot be distinguished.
###end p 27
###begin p 28
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 174 178 174 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 354 362 354 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyclin D</italic>
###xml 362 364 362 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myb </italic>
###xml 429 436 429 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bcl11a </italic>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pbx3 </italic>
###xml 558 572 558 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD59a antigen </italic>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rb1 </italic>
###xml 652 656 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Met </italic>
###xml 751 753 751 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 787 793 787 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 835 839 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 839 843 839 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 853 858 853 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten </italic>
###xml 888 889 888 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1057 1064 1057 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tensin </italic>
###xml 1120 1124 1120 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 1160 1167 1160 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 1178 1185 1178 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 1210 1216 1210 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 1393 1398 1393 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 1416 1419 1416 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 107 111 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 118 133 <span type="species:ncbi:10090">transgenic mice</span>
###xml 149 153 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 793 808 <span type="species:ncbi:10090">transgenic mice</span>
###xml 824 828 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 1205 1209 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1216 1231 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1388 1392 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1411 1415 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Permutation t test identified 113 genes that were differentially expressed (p < 0.001) between tumors from MMTV-Wnt-1 transgenic mice and those from MMTV-Wnt-1 transgenic/p53-/- mice (Table 2). Among the 113 genes, 43 were upregulated, and 70 were downregulated in the latter set of tumors (Additional data file 3). Examples of the upregulated genes are cyclin D2 (3.7-fold), Myb (2.9-fold and 2.8-fold for two separate clones), Bcl11a (1.5-fold), and Pbx3 (1.8-fold average), which promote proliferation or survival. Examples of the downregulated genes are CD59a antigen (two-fold), a potential p53 target [36], the Rb1 tumor suppressor gene, and the Met proto-oncogene. Using similar analyses, we found that 115 genes were differentially expressed (P < 0.001) between tumors from MMTV-Wnt-1 transgenic mice and those from MMTV-Wnt-1/Pten+/- mice with Pten loss of heterozygosity (Table 2). Forty-five were upregulated, and 70 of them were downregulated in the latter set of tumors (Additional data file 4). Interestingly, among the downregulated genes is tensin (two-fold), a cell adhesion molecule that is related to Pten. Similar to the comparison between Ha-Ras mutant and Ha-Ras wild-type tumors in MMTV-Wnt-1 transgenic mice, the number of genes differentially expressed and the average fold difference were much smaller in the above two comparisons than in the comparison between MMTV-Wnt-1-induced and MMTV-Neu-induced tumors (Additional data files 1, 3, and 4).
###end p 28
###begin p 29
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 397 403 397 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 54 58 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 65 80 <span type="species:ncbi:10090">transgenic mice</span>
###xml 392 396 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 403 418 <span type="species:ncbi:10090">transgenic mice</span>
###xml 505 520 <span type="species:ncbi:10090">transgenic mice</span>
Collectively, these findings suggest that tumors from MMTV-Wnt-1 transgenic mice are similar to each other in their global expression profiles, regardless of whether the tumors have additional genetic alterations. It is not known whether the modest differences in RNA levels we identified among these groups of tumors explain the accelerating effects of these alterations on tumorigenesis in MMTV-Wnt-1 transgenic mice. We plan to test some of these changes by expressing cDNAs in mammary glands in Wnt-1 transgenic mice using TVA-mediated somatic gene transfer technology [37].
###end p 29
###begin title 30
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 120 124 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 131 146 <span type="species:ncbi:10090">transgenic mice</span>
Distinct changes in gene expression accompany the evolution from normal mammary glands to hyperplasias and to tumors in MMTV-Wnt-1 transgenic mice
###end title 30
###begin p 31
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 393 399 393 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 783 789 783 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 882 892 882 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">keratin 19</italic>
###xml 894 904 894 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">calponin 1</italic>
###xml 910 920 910 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">calponin 2</italic>
###xml 1015 1021 1015 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 39 43 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 50 65 <span type="species:ncbi:10090">transgenic mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 399 414 <span type="species:ncbi:10090">transgenic mice</span>
###xml 778 782 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 789 804 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1010 1014 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1021 1036 <span type="species:ncbi:10090">transgenic mice</span>
Hyperplastic lesions are widespread in MMTV-Wnt-1 transgenic mice before the development of mammary tumors [14]. To determine whether unique gene expression patterns accompany the evolution from normal mammary cells to hyperplasias and then to tumors, we compared expression profiles among mammary glands of nontransgenic virgin mice, hyperplastic mammary glands, and mammary tumors from MMTV-Wnt-1 transgenic mice. Unsupervised hierarchical clustering analysis and MDS showed that expression profiles from these three groups of tissues were separated from each other (Figure 3a and data not shown). The difference between hyperplastic and normal glands is unlikely to be due to decreased contribution of stromal RNA in the preparation of RNAs from the hyperplastic glands from MMTV-Wnt-1 transgenic mice, because the expression levels of epithelial and myoepithelial marker genes (keratin 19, calponin 1, and calponin 2) were not significantly statistically different between hyperplastic mammary glands from MMTV-Wnt-1 transgenic mice and mammary glands from age-matched nontransgenic virgins.
###end p 31
###begin p 32
###xml 51 53 51 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 68 69 68 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 386 392 386 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 407 418 407 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">frizzled 7 </italic>
###xml 561 569 561 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 635 640 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP1 </italic>
###xml 655 698 655 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tumor-associated calcium signal transducer </italic>
###xml 791 793 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 112 116 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 123 138 <span type="species:ncbi:10090">transgenic mice</span>
In total, 584 genes were differentially expressed (P < 0.001, Table 1) between hyperplastic mammary glands from MMTV-Wnt-1 transgenic mice and normal mammary glands from nontransgenic littermates. Among these 584 genes, 121 were more highly expressed in the hyperplastic glands (Additional data file 5), which includes some of the known transcriptional targets of Wnt signaling such as c-Myc (3.6-fold) and frizzled 7 (2.1-fold). This list may therefore provide an important starting point for confirming mammary-specific target genes and for discovering novel in vivo targets of Wnt signaling. In fact, two genes in this list, namely RBP1 (2.9-fold) and tumor-associated calcium signal transducer (3.5-fold), were shown to be upregulated by beta-catenin in 293 cells in our recent studies [30].
###end p 32
###begin p 33
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 722 732 722 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">keratin 19</italic>
###xml 734 744 734 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">calponin 1</italic>
###xml 750 760 750 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">calponin 2</italic>
###xml 1185 1186 1185 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 200 204 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
One of the greatest challenges in identifying specific genes and expression patterns associated with the evolution from hyperplastic glands to tumors is the change in cellular composition. Normal and MMTV-Wnt-1-induced hyerplastic ductal trees are embedded in stroma, but tumors often contain much less stroma. Thus, the differential contribution of RNA from the stromal cells may skew array analysis, which is based on total RNA content. However, stromal cells are mostly large adipocytes whose RNA to mass ratio is small; thus, the relative contribution of RNA from these cells is probably much less than it appears to be from histologic assessment. The average expression level of epithelial and myoepithelial markers (keratin 19, calponin 1, and calponin 2) was 2.6-fold higher in the tumors (which contain very few stromal cells) than in the hyperplastic tissues, suggesting that 38% (1/2.6 = 38%) of the RNA in the hyperplastic tissues might come from the ducts and alveoli. Thus, to eliminate genes that were not truly differentially expressed, we filtered out any genes that were less than three-fold different in our comparison between tumors and hyperplastic glands in Table 2.
###end p 33
###begin p 34
###xml 433 439 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 528 530 528 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 580 581 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 688 708 688 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fat-specific gene 27</italic>
###xml 710 728 710 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lipoprotein lipase</italic>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD36</italic>
###xml 736 755 736 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">carbonic anhydrases</italic>
###xml 761 791 761 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">solute carrier family members </italic>
###xml 792 793 792 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 428 432 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 443 447 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 452 467 <span type="species:ncbi:10090">transgenic mice</span>
Based on the above calculation, approximately 62% of the RNAs from hyerplastic mammary glands might come from adipocyte-rich stroma. Thus, tumor samples, which have very little contribution from adipocytes, may appear to have downregulated the genes that are associated with adipocytes. In order to identify these genes, we compared the expression profiles of a set of three fat samples with those of the 35 mammary tumors from MMTV-Wnt-1 and MMTV-Neu transgenic mice. Expression of 741 genes was at least three-fold or higher (P < 0.001) in fat than in the mammary tumors (Table 2 and Additional data file 6). These include published fat-specific genes (Additional data file 6), such as fat-specific gene 27, lipoprotein lipase, CD36, carbonic anhydrases, and solute carrier family members [7]. We note these genes in our table comparing hyperplastic mammary glands with tumors (Additional data file 7).
###end p 34
###begin p 35
###xml 53 55 53 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Kit</italic>
###xml 602 608 602 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Kit </italic>
###xml 795 801 795 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1128 1134 1128 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 1218 1224 1218 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 1248 1250 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 108 112 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 119 134 <span type="species:ncbi:10090">transgenic mice</span>
###xml 790 794 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 801 816 <span type="species:ncbi:10090">transgenic mice</span>
###xml 911 916 <span type="species:ncbi:9606">human</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
###xml 1123 1127 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1134 1149 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1213 1217 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1224 1239 <span type="species:ncbi:10090">transgenic mice</span>
In total, 1,372 genes were differentially expressed (P < 0.001) between tumors and hyperplastic glands from MMTV-Wnt-1 transgenic mice. Among them, expression levels for 388 differed by at least three-fold (Additional data file 7). This subgroup is likely to contain genes that are important for the evolution of hyperplastic lesions into tumors, including genes that are required for tumor cell proliferation and survival. One such candidate is c-Kit, a proto-oncogene that is frequently overexpressed in cancers and that encodes a receptor that activates both Ras and Akt pathways. The expression of c-Kit was 3.6-fold higher in tumors than in hyperplastic lesions (Additional data file 7), although it was similarly expressed in normal virgin glands and hyperplastic mammary glands from MMTV-Wnt-1 transgenic mice. This is consistent with a recent report that c-Kit is highly expressed in the basal group of human breast tumors compared to other groups [38]. Using immunohistochemical staining, c-Kit protein was barely detectable in normal mammary glands from nontransgenic mice and in hyperplastic mammary glands from MMTV-Wnt-1 transgenic mice, but was readily and widely detected in the tumor samples from MMTV-Wnt-1 transgenic mice (Figure 3b).
###end p 35
###begin p 36
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 306 312 306 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 424 430 424 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 792 798 792 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 905 911 905 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 931 935 931 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 1059 1060 1059 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1144 1150 1144 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 1264 1269 1264 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 1305 1310 1305 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 1339 1342 1339 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu</italic>
###xml 1365 1366 1365 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1392 1394 1392 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1411 1420 1411 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNFRSF19 </italic>
###xml 1432 1437 1432 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NGFR </italic>
###xml 1449 1466 1449 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apolipoprotein D </italic>
###xml 1482 1488 1482 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt5a </italic>
###xml 1529 1531 1529 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1548 1554 1548 1554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BNIP3 </italic>
###xml 1569 1578 1569 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caveolin </italic>
###xml 1639 1656 1639 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apolipoprotein D </italic>
###xml 1729 1731 1729 1731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1898 1900 1898 1900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 103 107 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 114 129 <span type="species:ncbi:10090">transgenic mice</span>
###xml 301 305 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 312 327 <span type="species:ncbi:10090">transgenic mice</span>
###xml 419 423 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 430 445 <span type="species:ncbi:10090">transgenic mice</span>
###xml 644 648 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 655 670 <span type="species:ncbi:10090">transgenic mice</span>
###xml 787 791 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 798 813 <span type="species:ncbi:10090">transgenic mice</span>
###xml 900 904 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 926 930 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 935 950 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1139 1143 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1150 1165 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1259 1263 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1300 1304 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1334 1338 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1707 1712 <span type="species:ncbi:9606">human</span>
###xml 1871 1876 <span type="species:ncbi:9606">human</span>
Some of the genes that were differentially expressed between mammary tumors and hyperplastic glands in MMTV-Wnt-1 transgenic mice may be needed for evolution of tumors induced by both Wnt-1 and other oncogenes. Other genes may be uniquely important for induction of tumors from hyperplastic glands in MMTV-Wnt-1 transgenic mice. For example, certain signaling pathways may need to be activated in hyperplastic cells in MMTV-Wnt-1 transgenic mice before a tumor will form, but they may be optional for tumorigenesis initiated by other oncogenes. To discover genes that might be uniquely important for tumors to develop in hyperplastic glands in MMTV-Wnt-1 transgenic mice, we compared the 388 genes that we found to be differentially expressed between tumors and hyperplastic glands from MMTV-Wnt-1 transgenic mice with the 1,296 genes that we found to be differentially expressed between tumors from MMTV-Wnt-1 transgenic and MMTV-Neu transgenic mice. Fifty-six genes corresponding to 59 cDNA clones in the former group were shared in the latter group (Table 3), suggesting they might be specifically involved in neoplastic progression in MMTV-Wnt-1 transgenic mice. Among these 56 genes, 23 were more highly expressed and 33 were expressed at lower level in MMTV-Wnt-1-induced tumors than in either MMTV-Wnt-1-induced hyperplasia or MMTV-Neu-induced tumors (Table 3). The upregulated genes (P < 0.001) include TNFRSF19 (3.5-fold), NGFR (3.6-fold), apolipoprotein D (4.7-fold), and Wnt5a (4.4-fold), and the downregulated genes (P < 0.001) include BNIP3 (2.5-fold) and caveolin (2-, 3.3-, and 3.3-fold for three separate clones). Of note, apolipoprotein D has been reported to be upregulated in a subset of human breast cancers [39], and caveolin 1, a negative regulator of the Ras-p42/p44 mitogen-activated protein kinase cascade, has been reported to inhibit growth in human breast cancer cells [40].
###end p 36
###begin title 37
Conclusion
###end title 37
###begin p 38
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
###xml 341 345 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 352 367 <span type="species:ncbi:10090">transgenic mice</span>
Our analysis of different stages of tumorigenesis in mouse models identified changes in gene expression accompanying tumor initiation and evolution. We also extended the report by Desai and coworkers [7] that the initiating oncogene determines the expression profiles of primary mammary tumors. In addition, we observed that the tumors from MMTV-Wnt-1 transgenic mice are similar to each other in their global expression profiles, regardless of whether the tumors have additional genetic alterations. These data may be useful for elucidation of oncogenic signaling pathways in breast cancer initiation and evolution.
###end p 38
###begin title 39
Materials and methods
###end title 39
###begin title 40
cDNA microarray slides
###end title 40
###begin p 41
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse 15k slides and 8.7k slides used in this study were arrayed at the National Cancer Institute microarray facility. All slides of each array type were printed in a single batch. The 8.7k slides contain the 8700 Incyte GEM1 clone set, which are mapped to 6,877 Unigene cluster IDs, among which 2,953 are named genes, 2,206 are expressed sequence tags, and 1,628 are Riken cDNAs. The 15k slides contain the 8700 Incyte GEM1 clone set and the mammary 6000 clone set; a total of 1,444 clones do not map to a Unigene cluster ID, whereas the rest of the clones map to 10,062 unique genes as defined by Unigene cluster ID. Among the 10,062 Unigene clusters, 3,750 are named genes, 3,922 are expressed sequence taqs, and 2,390 are Riken cDNAs.
###end p 41
###begin title 42
Sample information
###end title 42
###begin p 43
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 22 26 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 101 105 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 112 127 <span type="species:ncbi:10090">transgenic mice</span>
###xml 189 193 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 198 213 <span type="species:ncbi:10090">transgenic mice</span>
###xml 314 317 <span type="species:ncbi:10116">rat</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 625 628 <span type="species:ncbi:9685">Cat</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
All nontransgenic and MMTV-Neu transgenic animals used in this study were on the FVB background. All MMTV-Wnt-1 transgenic mice [14] were a mixture of FVB (>75%), SJL, and C57BL/6 strains. MMTV-Neu transgenic mice [41] were purchased from Jackson Laboratories (Bar Harbor, ME, USA). This transgenic line carries a rat cDNA encoding the wild-type Neu protein. Fat tissues were collected from intestinal fat in virgin FVB mice. All samples were collected fresh and snap-frozen in liquid nitrogen. RNA was extracted by Trizol (Invitorgen, Carlsbad, CA, USA). Reference RNA was a mixture of ovarian RNA (Ambion, Austin, TX, USA; Cat number 7824) and RNA extracted from tissues of liver, spleen, kidney, thymus, pancreas, lung, and normal lactating mammary gland of FVB mice of 6 months of age. All reference RNA used in this study is from a single preparation.
###end p 43
###begin title 44
cDNA microarray hybridization and data extraction
###end title 44
###begin p 45
###xml 154 156 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 157 159 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 477 479 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 480 482 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 816 818 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
The cDNA probes were prepared from a total of 35-50 mug reference RNA and 50-75 mug sample RNA from normal, hyperplastic, or tumor tissues, as described [42,43]. The cDNA from reference RNA was labeled with cyanine 3-dUTP, and that from sample RNA was labeled with cyanine 5-dUTP. Fluorescent images of hybridized microarrays were obtained by using a GenePix 4000 scanner (Axon Instruments, Foster City, CA, USA). Microarray images were analyzed using the ArraySuite software [44,45] based on the Scanalytics IPlab platform (Scanalytics, Fairfax, VA, USA). For each cDNA probe location, fluorescence intensity ratio and its associated measurement quality (q) were calculated. The evaluation of measurement quality is based on spot size, signal to noise ratio, background uniformity, and saturation pixel percentage [45]. The range of measurement quality is from 1.0 to 0, with higher measurements reflecting better quality. Areas of the array with obvious blemishes were automatically given a low quality value.
###end p 45
###begin title 46
Statistical analysis of cDNA microarray data
###end title 46
###begin p 47
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
Normalized log test to reference ratios and their corresponding quality measurements in each experiment were calculated as described previously [45]. A gene was excluded from further analyses (see below for description) if the average quality measurement was under 0.5 across samples in that specific comparison. Approximately 14,000 genes are suitable for analyzing on the 15k chips and 8,000 genes on the 8.7k chips.
###end p 47
###begin p 48
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
Two methods were used to visualize the expression patterns among samples. Both used the Pearson correlation as a similarity measure. In average linkage hierarchical clustering, the distances between samples are represented on a tree called a dendrogram. In MDS, samples with similar expression ratios were placed closer to each other in three dimensional space. Average linkage hierarchical clustering analysis was implemented using the CLUSTER program, and the results were displayed using TREEVIEW [46]. MDS was developed in the MATLAB (Natick, MA, USA) environment.
###end p 48
###begin p 49
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 375 377 375 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 532 534 532 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 817 819 817 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
A permutation t-test was used to select genes significantly differentially expressed between any two groups [47]. Here, a standard t-statistic was computed between two groups on the log-transformed ratios of each gene. The group labels were randomly permuted and the t-statistic for each gene in the permuted data set was calculated. The process was repeated 10,000 times. A P value was reported for each gene by comparing the observed statistic with the permutation statistics. To control for multiple comparisons, only genes with P values less than 0.001 were considered differentially expressed. The distribution of the significant differences expected by chance and the probability of observing as many or more differentially expressed genes were calculated from the permuted data. This latter probability is the P value reported in the Results and discussion section.
###end p 49
###begin title 50
Western blot analysis and immunohistochemical staining
###end title 50
###begin p 51
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 24 30 <span type="species:ncbi:9986">rabbit</span>
Antibodies used include rabbit IgG directed against nidogen and c-Kit (Santa Cruz, CA, USA). Tissues were fixed in 10% neutral formalin and processed as previously described [34] to obtain paraffin sections of 4 mum in thickness. For immunohistochemistry, the sections were boiled for 15 minutes in 10 mmol/l citrate buffer of pH 6.0 (to unmask antigen epitopes). Endogenous peroxidase activity was inactivated by 10 minute incubation in 3% hydrogen peroxide, and subsequent steps were performed using Vector ABC kits and the Nova-Red substrate (Vector Laboratories, Burlingame, CA, USA) following the manufacturer's recommendations.
###end p 51
###begin p 52
For Western blotting, tumors were ground to powder in liquid nitrogen and lysed in the M-PER tissue lysis solution (Pierce, Rockford, IL, USA) with gentle shaking overnight at 4degreesC. Proteins in resulting supernatant (25 mug protein) were denatured using 2-mercaptoethanol, resolved on 10% polyacrylamide mini-gels containing 10% sodium dodecyl sulfate, and transferred to nitrocellulose membranes. The membranes were then incubated with primary antibodies and peroxidase-conjugated secondary antibodies (Jackson Laboratories) in tris-borate buffer (1 mmol/l Tris and 13.7 mmol/l NaCl, pH 7.6)/0.05% Tween 20/5% nonfat dried milk. Proteins recognized by specific antibodies were visualized using a chemiluminescent substrate (Supersignal; Pierce).
###end p 52
###begin title 53
Accession number
###end title 53
###begin p 54
The GEO accession number for the series of array data-sets is GSE2860.
###end p 54
###begin title 55
Additional data files
###end title 55
###begin p 56
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 281 288 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 331 337 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 452 455 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 591 597 591 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 608 612 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 612 616 612 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten </italic>
###xml 683 689 683 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 700 704 700 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 704 708 704 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 735 736 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 882 888 882 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 926 927 926 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1032 1038 1032 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 1047 1051 1047 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 1089 1090 1089 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
###xml 1209 1215 1209 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 1253 1254 1253 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 160 164 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 175 179 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 184 199 <span type="species:ncbi:10090">transgenic mice</span>
###xml 326 330 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 586 590 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
###xml 877 881 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 888 903 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1042 1046 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1051 1066 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1204 1208 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1215 1230 <span type="species:ncbi:10090">transgenic mice</span>
The following additional data are available with the online version of this article: a table listing genes differentially expressed between mammary tumors from MMTV-Wnt-1 and MMTV-Neu transgenic mice (Additional data file 1); a table listing genes differentially expressed between Ha-Ras mutant and Ha-Ras wild-type tumors in MMTV-Wnt-1 mice (Additional data file 2); a table listing genes differentially expressed between MMTV-Wnt-1-induced tumors in p53-null and in p53-wild-type background (Additional data file 3); a table listing genes differentially expressed between tumors from MMTV-Wnt-1 transgenic/Pten+/- mice with loss of heterozygosity at the Pten locus and tumors from Wnt-1 transgenic/Pten+/+ mice (Additional data file 4); a table listing genes differentially expressed between virgin mammary glands from nontransgenic mice and hyperplastic mammary glands from MMTV-Wnt-1 transgenic mice (Additional data file 5); a table listing genes expressed three-fold or higher in fat tissues than in mammary tumors from MMMTV-Wnt-1 and MMTV-Neu transgenic mice (Additional data file 6); and a table listing genes differentially expressed between mammary tumors and hyperplastic mammary glands from MMTV-Wnt-1 transgenic mice (Additional data file 7).
###end p 56
###begin title 57
Supplementary Material
###end title 57
###begin title 58
Additional File 1
###end title 58
###begin p 59
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 75 79 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 90 94 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 99 114 <span type="species:ncbi:10090">transgenic mice</span>
A table listing genes differentially expressed between mammary tumors from MMTV-Wnt-1 and MMTV-Neu transgenic mice
###end p 59
###begin p 60
Click here for file
###end p 60
###begin title 61
Additional File 2
###end title 61
###begin p 62
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 105 111 105 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 100 104 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
A table listing genes differentially expressed between Ha-Ras mutant and Ha-Ras wild-type tumors in MMTV-Wnt-1 mice
###end p 62
###begin p 63
Click here for file
###end p 63
###begin title 64
Additional File 3
###end title 64
###begin p 65
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 55 59 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
A table listing genes differentially expressed between MMTV-Wnt-1-induced tumors in p53-null and in p53-wild-type background
###end p 65
###begin p 66
Click here for file
###end p 66
###begin title 67
Additional File 4
###end title 67
###begin p 68
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 93 97 93 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten </italic>
###xml 164 170 164 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 185 189 185 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 67 71 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
A table listing genes differentially expressed between tumors from MMTV-Wnt-1 transgenic/Pten+/- mice with loss of heterozygosity at the Pten locus and tumors from Wnt-1 transgenic/Pten+/+ mice
###end p 68
###begin p 69
Click here for file
###end p 69
###begin title 70
Additional File 5
###end title 70
###begin p 71
###xml 143 149 143 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 149 164 <span type="species:ncbi:10090">transgenic mice</span>
A table listing genes differentially expressed between virgin mammary glands from nontransgenic mice and hyperplastic mammary glands from MMTV-Wnt-1 transgenic mice
###end p 71
###begin p 72
Click here for file
###end p 72
###begin title 73
Additional File 6
###end title 73
###begin p 74
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 112 116 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 121 136 <span type="species:ncbi:10090">transgenic mice</span>
A table listing genes expressed three-fold or higher in fat tissues than in mammary tumors from MMMTV-Wnt-1 and MMTV-Neu transgenic mice
###end p 74
###begin p 75
Click here for file
###end p 75
###begin title 76
Additional File 7
###end title 76
###begin p 77
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 107 111 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 118 133 <span type="species:ncbi:10090">transgenic mice</span>
A table listing genes differentially expressed between mammary tumors and hyperplastic mammary glands from MMTV-Wnt-1 transgenic mice
###end p 77
###begin p 78
Click here for file
###end p 78
###begin title 79
Acknowledgements
###end title 79
###begin p 80
We thank Patrick O Brown, Michael B Eisen, Vishy Iyer, Nick Socci, Larry Donehower, Xinbin Chen, and Alfonso Bellacosa for advice and members of the Varmus laboratory for helpful discussion. We thank Xiaomei Zhang for immunohistochemical staining and Gary Chamness for assistance in the preparation of this manuscript. We thank Raju Chaganti for providing access to the scanner and Veronique Bourdon for assistance in its use. S.H. was supported by Department of Defense Breast Cancer Research Program awards. This work was supported in part by a National Institutes of Health Grant P01 CA94060-02 (to H.E.V.) and funds from the Martell Foundation (to H.E.V.) and Department of Defense (USAMRMC) BC030755 (to Y.L.).
###end p 80
###begin article-title 81
###xml 65 70 <span type="species:ncbi:9606">human</span>
Laser capture microdissection and advanced molecular analysis of human breast cancer.
###end article-title 81
###begin article-title 82
###xml 10 17 <span type="species:ncbi:9606">patient</span>
Improving patient care through molecular diagnostics.
###end article-title 82
###begin article-title 83
###xml 28 33 <span type="species:ncbi:9606">human</span>
Gene expression profiles of human breast cancer progression.
###end article-title 83
###begin article-title 84
Molecular markers in ductal carcinoma in situ of the breast.
###end article-title 84
###begin article-title 85
A SAGE (serial analysis of gene expression) view of breast tumor progression.
###end article-title 85
###begin article-title 86
###xml 5 9 <span type="species:ncbi:10090">mice</span>
###xml 13 19 <span type="species:ncbi:9606">humans</span>
From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies.
###end article-title 86
###begin article-title 87
###xml 66 71 <span type="species:ncbi:9606">human</span>
Initiating oncogenic event determines gene-expression patterns of human breast cancer models.
###end article-title 87
###begin article-title 88
Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.
###end article-title 88
###begin article-title 89
###xml 27 52 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.
###end article-title 89
###begin article-title 90
Wnt genes.
###end article-title 90
###begin article-title 91
Wnt proteins in mammary development and cancer.
###end article-title 91
###begin article-title 92
Beta-catenin and Tcfs in mammary development and cancer.
###end article-title 92
###begin article-title 93
Convergence of Wnt, beta-catenin, and cadherin pathways.
###end article-title 93
###begin article-title 94
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice.
###end article-title 94
###begin article-title 95
The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells.
###end article-title 95
###begin article-title 96
Stem cells and breast cancer: a field in transit.
###end article-title 96
###begin article-title 97
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
###end article-title 97
###begin article-title 98
The ErbB signaling network: receptor heterodimerization in development and cancer.
###end article-title 98
###begin article-title 99
###xml 52 67 <span type="species:ncbi:10090">transgenic mice</span>
Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
###end article-title 99
###begin article-title 100
###xml 48 52 <span type="species:ncbi:10090">mice</span>
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.
###end article-title 100
###begin article-title 101
Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.
###end article-title 101
###begin article-title 102
Identification of c-MYC as a target of the APC pathway.
###end article-title 102
###begin article-title 103
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
###end article-title 103
###begin article-title 104
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.
###end article-title 104
###begin article-title 105
Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
###end article-title 105
###begin article-title 106
###xml 45 50 <span type="species:ncbi:9606">human</span>
A transcriptional response to Wnt protein in human embryonic carcinoma cells.
###end article-title 106
###begin article-title 107
###xml 61 66 <span type="species:ncbi:9606">human</span>
Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid.
###end article-title 107
###begin article-title 108
Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling.
###end article-title 108
###begin article-title 109
Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein.
###end article-title 109
###begin article-title 110
FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.
###end article-title 110
###begin article-title 111
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
###end article-title 111
###begin article-title 112
###xml 54 59 <span type="species:ncbi:9606">human</span>
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.
###end article-title 112
###begin article-title 113
###xml 7 11 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 18 33 <span type="species:ncbi:10090">transgenic mice</span>
Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer.
###end article-title 113
###begin article-title 114
###xml 54 58 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 65 80 <span type="species:ncbi:10090">transgenic mice</span>
Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice.
###end article-title 114
###begin article-title 115
###xml 61 76 <span type="species:ncbi:10090">transgenic mice</span>
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.
###end article-title 115
###begin article-title 116
The complement inhibitor CD59 and the lymphocyte function-associated antigen-3 (LFA-3, CD58) genes possess functional binding sites for the p53 tumor suppressor protein.
###end article-title 116
###begin article-title 117
###xml 78 84 <span type="species:ncbi:10090">murine</span>
Development of a flexible and specific gene delivery system for production of murine tumor models.
###end article-title 117
###begin article-title 118
Breast cancer classification and prognosis based on gene expression profiles from a population-based study.
###end article-title 118
###begin article-title 119
###xml 44 49 <span type="species:ncbi:9606">human</span>
In vivo gene expression profile analysis of human breast cancer progression.
###end article-title 119
###begin article-title 120
###xml 58 63 <span type="species:ncbi:9606">human</span>
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells.
###end article-title 120
###begin article-title 121
###xml 65 80 <span type="species:ncbi:10090">transgenic mice</span>
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
###end article-title 121
###begin article-title 122
Exploring the metabolic and genetic control of gene expression on a genomic scale.
###end article-title 122
###begin article-title 123
###xml 47 50 <span type="species:ncbi:10116">rat</span>
Identification of c-myc responsive genes using rat cDNA microarray.
###end article-title 123
###begin article-title 124
Ratio-based decusuibs abd quantitative analysis of cDNA microarray images.
###end article-title 124
###begin article-title 125
Ratio statistics of gene expression levels and applications to microarray data analysis.
###end article-title 125
###begin article-title 126
Cluster analysis and display of genome-wide expression patterns.
###end article-title 126
###begin article-title 127
Gene-expression profiles in hereditary breast cancer.
###end article-title 127
###begin title 128
Figures and Tables
###end title 128
###begin p 129
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 83 87 83 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 283 290 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ha-Ras </italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 382 386 382 386 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 482 488 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 39 43 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 57 61 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 66 81 <span type="species:ncbi:10090">transgenic mice</span>
###xml 293 297 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 477 481 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 492 496 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 501 516 <span type="species:ncbi:10090">transgenic mice</span>
###xml 518 522 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 524 549 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
###xml 577 581 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 586 601 <span type="species:ncbi:10090">transgenic mice</span>
###xml 629 633 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 640 655 <span type="species:ncbi:10090">transgenic mice</span>
Gene expression in mammary tumors from MMTV-Wnt-1 versus MMTV-Neu transgenic mice. (a) Dendrogram of 35 mammary tumors analyzed by average linkage hierarchical clustering analysis using 1,932 genes selected for high variability across all tumors. 15k arrays were used. The status of Ha-Ras on MMTV-Wnt-1-induced tumors is color coded: red, wild-type; brown, mutant; green, unknown. (b) Western blot analysis for nidogen protein expression on representative mammary tumors from MMTV-Wnt-1 and MMTV-Neu transgenic mice. MMTV, mouse mammary tumor virus; NeuT, mammary tumors from MMTV-Neu transgenic mice; WntT, mammary tumors from MMTV-Wnt-1 transgenic mice.
###end p 129
###begin p 130
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WntT</italic>
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten+/- </italic>
###xml 256 262 256 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten</italic>
###xml 277 281 277 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pten </italic>
###xml 358 363 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1</italic>
###xml 364 367 364 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P53</italic>
###xml 367 371 367 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 101 105 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 107 132 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
###xml 160 164 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 171 186 <span type="species:ncbi:10090">transgenic mice</span>
###xml 251 255 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
Multidimensional scaling analysis of 18 tumor samples of indicated genotypes. 8.7k arrays were used. MMTV, mouse mammary tumor virus; WntT, mammary tumors from MMTV-Wnt-1 transgenic mice; WntT/Pten+/- loss of heterozygosity (LOH), mammary tumors from MMTV-Wnt-1 transgenic/Pten+/- mice with Pten loss of heterozygosity; WntT/P53-/-, mammary tumors from MMTV-Wnt-1/P53-/- mice.
###end p 130
###begin p 131
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 74 78 74 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 255 259 255 259 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 474 480 474 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 541 547 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 46 50 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 57 72 <span type="species:ncbi:10090">transgenic mice</span>
###xml 358 362 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 364 389 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 480 495 <span type="species:ncbi:10090">transgenic mice</span>
###xml 536 540 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 547 562 <span type="species:ncbi:10090">transgenic mice</span>
Gene expression in mammary tumor evolution in MMTV-Wnt-1 transgenic mice. (a) Dendrogram of 35 samples analyzed by average linkage hierarchical clustering analysis, using 3,359 genes selected for high variability across all samples. 15k arrays were used. (b) Immunohistochemical staining for c-Kit in the indicated tissue sections. A 20x objective was used. MMTV, mouse mammary tumor virus; VMG, virgin mammary glands from nontransgenic mice; WntT, mammary tumors from MMTV-Wnt-1 transgenic mice; WntH, hyperplastic mammary glands from MMTV-Wnt-1 transgenic mice.
###end p 131
###begin p 132
Tissue samples
###end p 132
###begin p 133
###xml 29 33 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 35 60 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
LOH, loss of heterozygosity; MMTV, mouse mammary tumor virus.
###end p 133
###begin p 134
Numbers of genes that are differentially expressed
###end p 134
###begin p 135
###xml 218 220 218 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Expression ratio is computed by dividing the average expression level of the A group by the average expression level of the B group. The numbers of differentially expressed genes were determined by random permutation (P < 0.001), as described in the Materials and method section. *In selected comparisons, to reduce potential false signals due to stromal effects, the genes that were less than three-fold different in expression were filtered out from the listed total number of genes. LOH, loss of heterozygosity.
###end p 135
###begin p 136
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 77 81 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 88 103 <span type="species:ncbi:10090">transgenic mice</span>
List of genes potentially specifically involved in neoplastic progression in MMTV-Wnt-1 transgenic mice
###end p 136
###begin p 137
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wnt-1 </italic>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neu </italic>
###xml 132 136 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 143 158 <span type="species:ncbi:10090">transgenic mice</span>
###xml 240 244 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 249 264 <span type="species:ncbi:10090">transgenic mice</span>
###xml 637 641 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 643 668 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
This list displays genes that are differentially expressed between mammary tumors (WntT) and hyperplastic mammary gland (WntH) from MMTV-Wnt-1 transgenic mice, and that are also differentially expressed between WntT and mammary tumors from MMTV-Neu transgenic mice (NeuT). Genes are sorted according to the average ratio of WntT versus WntH. A numeric ratio is displayed if the gene expression meets the criteria (statistical significance and fold cutoff) described in Table 2; otherwise, it is marked as '=', indicating that there is no significant difference between the two sets of samples in comparison. EST, expressed sequence tag; MMTV, mouse mammary tumor virus.
###end p 137

